Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 268-276

  Khan, Anis ^a   Kurbanov, Fuat ^a   Tanaka, Yasuhito ^a   Elkady, Abeer ^a   Sugiyama, Masaya ^a   Dustov, Abdusamad ^b   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Academy of Sciences of the Republic of Tadzhikistan   (Tajikistan)

Author keywords

Genotype; HBV; HCV; HDV; Molecular epidemiology; Mutations BCP; Tajikistan

Indexed keywords

COMPLEMENTARY DNA; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; COMORBIDITY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PREVALENCE; TAJIKISTAN; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS HEPATITIS;

ADOLESCENT; ADULT; CLUSTER ANALYSIS; COMORBIDITY; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; TAJIKISTAN;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 37549064779     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21057     Document Type: Article

References (48)

1. Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 37:1802-1808.
2. Baptista M, Kramvis A, Kew MC. 1999. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29:946-953.
3. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. 1996. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70:5845-5851.
4. Casey JL, Niro GA, Engle RE, Vega A, Gomez H, McCarthy M, Watts DM, Hyams KC, Gerin JL. 1996. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: The roles of HDV genotype III and HBV genotype F. J Infect Dis 174:920-926.
5. Chu CM, Yeh CT, Liaw YF. 1998. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 36:2084-2086.
6. Chu CJ, Hussain M, Lok AS. 2002. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36:1408-1415.
7. Hashimoto M, Chayama K, Tubota A, Kobayashi M, Saitou S, Arase Y, Ikeda K, Kobayashi M, Nakano A, Takagi K, Koike H, Okamoto K, Handa H, Kumada H. 1996. Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region. Int Hepatol Commun 4:263-267.
8. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. 2002. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology 35:665-672.
9. Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL. 2003. Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1. J Infect Dis 187:1071-1074.
10. Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, Yuen MF, Lai CL, Gish RG, Ueda R, Mizokami M. 2006. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Clin Infect Dis 42:1-7.
11. Kalinina O, Norder H, Mukomolov S, Magnius LO. 2002. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76:4034-4043.
12. Kao JH, Chen PJ, Lai MY, Chen DS. 2003. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327-334.
13. Kato H, Ruzibakiev R, Yuldasheva N, Hegay T, Kurbanov F, Achundjanov B, Tuichiev L, Usuda S, Ueda R, Mizokami M. 2002. Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping. J Med Virol 67:477-483.
14. Kuiken C, Mizokami M, Deleage G, Yusim K, Penin F, Shin IT, Charavay C, Tao N, Crisan D, Grando D, Dalwani A, Geourjon C, Agrawal A, Combet C. 2006. Hepatitis C databases, principles and utility to researchers. Hepatology 43:1157-1165.
15. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. 2003. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 69:367-375.
16. Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, Zekeng L, Ndembi N, Ngansop C, Kaptue L, Miura T, Ido E, Hayami M, Ichimura H, Mizokami M. 2005. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 86:2047-2056.
17. Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M. 2007. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. J Viral Hepat 14:667-674.
18. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
19. Lusida MI, Surayah, Sakugawa H, Nagano-Fujii M, Soetjipto, Mulyanto, Handajani R, Boediwarsono, Setiawan PB, Nidom CA, Ohgimoto S, Hotta H. 2003. Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia. Microbiol Immunol 47:969-975.
20. Lvov DK, Samokhvalov EI, Tsuda F, Selivanov NA, Okamoto H, Stakhanova VM, Stakhgildyan IV, Doroshenko NV, Yashina TL, Kuzin SN, Suetina IA, Deryabin PG, Ruzaeva LA, Bezgodov VN, Firsova LA, Sorinson SN, Mishiro S. 1996. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. Arch Virol 141:1613-1622.
21. Miyakawa Y, Mizokami M. 2003. Classifying hepatitis B virus genotypes. Intervirology 46:329-338.
22. Nakano T, Shapiro CN, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH. 2001. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 82:2183-2189.
23. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. 1997. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 29:23-28.
24. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
25. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, Mukaide M, Williams R, Lau JY. 1997. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 35:201-207.
26. Oyunsuren T, Kurbanov F, Tanaka Y, Elkady A, Sanduijav R, Khajidsuren O, Dagvadorj B, Mizokami M. 2006. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 78:1688-1695.
27. Pawlotsky JM. 2003a. Hepatitis C virus genetic variability: Pathogenic and clinical implications. Clin Liver Dis 7:45-66.
28. Pawlotsky JM. 2003b. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 59:1-11.
29. Ruzibakiev R, Kato H, Ueda R, Yuldasheva N, Hegay T, Avazova D, Kurbanov F, Zalalieva M, Tuichiev L, Achundjanov B, Mizokami M. 2001. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan. Intervirology 44:327-332.
30. Schaefer S. 2005. Hepatitis B virus: Significance of genotypes. J Viral Hepat 12:111-124.
31. Semiletov Iu A, Pimenov VK, Ianina MV, Zubov SV, Shibnev VA. 2002. Test for specific antibodies to virus hepatitis delta based on synthetic peptides. Vopr Virusol 47:21-24.
32. Sheen IS, Liaw YF, Lin DY, Chu CM. 1994. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: A multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-361.
33. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Akinfeeva LA, Rakova IG, Aleshina MV, Bukin VN, Orlovsky VG, Bespalov VS, Robertson BH, Netesov SV. 2005. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 77:382-389.
34. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
35. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WG. 2001. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: Complete genome sequence and phylogenetic relatedness. J Gen Virol 82:883-892.
36. Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M. 2004. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol 85:811-820.
37. Suzuki K, Mizokami M, Cao K, Wu XS, Wu RR, Hata A, Sasaki M, Fang ZX, Zhang LY, Lau JY, Iino S. 1997. Prevalence of hepatitis C virus infection in Nanjing, southern China. Eur J Epidemiol 13:511-515.
38. Takahashi K, Ohta Y, Kanai K, Akahane Y, Iwasa Y, Hino K, Ohno N, Yoshizawa H, Mishiro S. 1999. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol 144:1299-1308.
39. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, Alter HJ. 2000. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32:388-393.
40. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. 2002. Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 99:15584-15589.
41. Tanaka Y, Takagi K, Fujihara T, Kitsugi K, Fujiwara K, Hiramatsu K, Ito Y, Takasaka Y, Sakai M, Mizokami M. 2003. High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature. Hepatol Res 26:261-267.
42. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, Mayumi M. 1999. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 80:97-112.
43. Verbeeck J, Maes P, Wollants E, Van der Merwe S, Song E, Nevens F, Van Ranst M. 2005. Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains. J Clin Microbiol 43:6117-6119.
44. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, Vasychova F, Widell A, Roggendorf M. 1997. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova, and Uzbekistan). J Med Virol 53:36-40.
45. Vorozhbieva TE, Iasinskii AV, Alieva G, Mikhailov MI, Iavorkovskaia EK. 1985. Characteristics of the distribution of the markers of hepatitis B vir us infection among the healthy population of the Tadzhik SSR and Azerbaijan SSR. Zh Mikrobiol Epidemiol Immunobiol 10:35-39.
46. Wu JC, Chiang TY, Sheen IJ. 1998. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol 79:1105-1113.
47. Yu ML, Chuang WL, Chen SC, Dai CY, Hou C, Wang JH, Lu SN, Huang JF, Lin ZY, Hsieh MY, Tsai JF, Wang LY, Chang WY. 2001. Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 65:58-65.
48. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.